Screener
Century Therapeutics IPSC Q2 2026 earnings
Reported August 12, 2026 · Before market open
EPS-$0.17Miss by $0.06
Revenue estimate$2.2M
EPS estimate-$0.11
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$1.6M
EPS estimate-$0.12
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Century Therapeutics report Q2 2026 earnings?
- Century Therapeutics (IPSC) reported Q2 2026 earnings on August 12, 2026 before market open.
- What were Century Therapeutics's Q2 2026 revenue and EPS?
- Century Therapeutics reported eps of $-0.17 for Q2 2026.
- Did Century Therapeutics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.11 by $0.06.
- How did Century Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 55.3% from $-0.38.
- Where can I find Century Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-094533) and the 10-Q periodic report (0001104659-26-094523) directly on SEC EDGAR. The filing index links above go to sec.gov.
